Press releases
-
ICON’s Acquisition of MeDiNova Research
The acquisition further enhances ICON’s patient recruitment capabilities in EMEA and complements ICON’s existing site network in the US, PMG Research. -
ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research
ICON Wins Multiple Awards at the 2019 Clinical and Research Excellence Awards -
ICON Launches New Patient Engagement Platform to Support Improved Patient Experience & Enrolment in Clinical Trials
Increasing visibility of potential study participants to sites and sponsors. -
ICON Reports First Quarter 2019 Results
Net business wins (including pass-through) in the quarter of $885 million; a book to bill of 1.31. -
Forbes names ICON one of the best employers in America
ICON ranked top CRO in anonymous survey of 50,000 employees across 38 sectors -
ICON wins multiple categories in 2019 CRO Leadership Awards
ICON recognised for specialised services offering across product development lifecycle -
ICON Acquires MolecularMD
ICON enhances it molecular diagnostic testing services, a key area in oncology research, with it's acquisition of MolecularMD. -
ICON Reports Fourth Quarter and Full Year 2018 Results
Full year reported revenue was $2,595.8 million. Excluding the impact of ASC 606, full year revenue increased to $1,897.6 million from $1,758.4 million in 2017, an increase of 7.9%. -
ICON Launches New Drug Safety Reporting Solution Ensuring Compliance Through Automation
Developed on platform deploying rule-based automation for timely delivery of drug safety information. -
